Honeywell Reports Third Quarter Results; Updates 2025 Guidance
- Sales of
$10.4 Billion , Reported Sales Up 7%, Organic1 Sales Up 6%, Exceeding High End of Previous Guidance - Earnings Per Share of
$2.86 and Adjusted Earnings Per Share1 of$2.82 , Exceeding High End of Previous Guidance - Orders Up 22%, Led by Strength in Aerospace Technologies and Energy and Sustainability Solutions
- Company Raises Full-Year Organic Growth and Adjusted Earnings Per Share Guidance, Including Impact from Advanced Materials Spin
- Announced New Segmentation and Simplified Structure Focused on Cohesive Business Models and Aligned to Post-Separation Automation Pure-Play Strategy, Expected Beginning First Quarter 2026
- Separations Progressing on Track with Spin-Off of Solstice Advanced Materials Set for
October 30, 2025
The company reported third-quarter year-over-year sales growth of 7% and organic1 sales growth of 6%, led by double-digit organic sales growth in commercial aftermarket and defense and space. Operating income decreased 6% and segment profit1 increased 5% to
Kapur added, "Looking ahead, we are well positioned to continue building on our momentum and value creation efforts in the fourth quarter. Today, we are raising our full-year 2025 adjusted earnings per share guidance even while separating Solstice Advanced Materials at the end of October. We will remain focused on our compelling opportunities to deliver outcomes-based solutions to customers and are encouraged by the recent execution of our connected offerings through our
As a result of the company's third-quarter performance and management's outlook for the remainder of the year,
Full-year sales are now expected to be
Excluding the impact of the Bombardier agreement4 signed in the fourth quarter of 2024, the company expects organic sales1 growth of approximately 5%, segment margin2 down 40 to 30 basis points year over year, and adjusted earnings per share2,3 up approximately 3% year over year. The company expects adjusted earnings per share growth of 5% to 6% when excluding both the impact of the Bombardier agreement4 and the October spin-off of Solstice Advanced Materials. A summary of the company's full-year guidance changes can be found in Table 1.
Portfolio Transformation
In February, Honeywell announced that its Board of Directors concluded its comprehensive portfolio review and decided to pursue a separation of its
In preparation for the separation,
- Most recently, the company announced its reorganization into a simplified structure for its automation businesses with three reporting segments - Building Automation, Process Automation and Technology, and
Industrial Automation - expected beginning first quarter 2026. The new segments will be focused on cohesive business models and aligned to the company's post-separation automation pure-play strategy. The company will continue to report Aerospace Technologies as a reporting segment through the planned separation in the second half of 2026. - In October, the company announced the divestiture of its Bendix-related legacy asbestos liabilities. In combination with the July termination of an indemnification and reimbursement agreement with Resideo related to legacy environmental liabilities for which
Honeywell received$1.6 billion , these transactions will increase management capacity and free up capital to pursue new value-enhancing opportunities. - In July, the company initiated an evaluation of strategic alternatives for its productivity solutions and services and warehouse and workflow solutions businesses as part of its process to simplify its portfolio.
- Also during the quarter, the company announced that Quantinuum raised over
$600 million at a$10 billion pre-money valuation to fund the advance of quantum computing at scale.
Third-Quarter Performance
Aerospace Technologies sales for the third quarter grew 12% organically1 year over year, led by strong performance in commercial aftermarket and defense and space. Commercial aftermarket sales increased 19% from the previous year, supported by ongoing supply chain unlock, with balanced growth across business jet and air transport end markets. Defense and space grew 10% year over year, its seventh consecutive quarter of double-digit growth, as global demand remains elevated. Commercial original equipment returned to growth in the quarter on higher shipment volumes. Overall backlog increased year over year as orders grew at a strong double-digit rate. Segment margin declined 160 basis points to 26.1% as commercial excellence and volume leverage were more than offset by cost inflation and the impact of acquisitions.
Building Automation sales for the third quarter increased 7% organically1 from the previous year. Building solutions delivered growth of 7%, led by continued gains in
Energy and Sustainability Solutions sales for the third quarter decreased 2% year over year on an organic basis. Advanced materials grew 5% in the quarter, driven by strength in refrigerants. UOP sales declined 13% as anticipated licensing delays and lower catalyst shipment volumes offset continued growth in sustainability solutions. Orders grew double digits in the quarter, with strong performance in both advanced materials and UOP. Segment margin remained flat year over year at 24.5% as a one-time
Conference Call Details
TABLE 1: FULL-YEAR 2025 GUIDANCE 2
| ||||
Previous Guidance | Solstice Spin Impact | Adjusted Previous | Current Guidance | |
Sales | ~( | |||
Organic1 Growth | 4% - 5% | ~6% | ||
Segment Margin | 23.0% - 23.2% | 22.9% - 23.0% | ||
Expansion | Up 40 - 60 bps | Up 30 - 40 bps | ||
Adjusted Earnings Per Share3 | ~( | |||
Adjusted Earnings Growth3 | 6% - 8% | 7% - 8% | ||
Operating Cash Flow | ||||
Free Cash Flow1 | ~( | |||
TABLE 2: SUMMARY OF (Dollars in millions, except per share amounts) | ||||||
3Q 2025 | 3Q 2024 | Change | ||||
Sales | 7 % | |||||
Organic1 Growth | 6 % | |||||
Operating Income | (6) % | |||||
Operating Income Margin | 16.9 % | 19.1 % | -220 bps | |||
Segment Profit1 | 5 % | |||||
Segment Margin1 | 23.1 % | 23.6 % | -50 bps | |||
Earnings Per Share | 32 % | |||||
Adjusted Earnings Per Share1 | 9 % | |||||
Operating Cash Flow | 65 % | |||||
Free Cash Flow1 | (16 %) | |||||
TABLE 3: SUMMARY OF SEGMENT FINANCIAL RESULTS (Dollars in millions)
| ||||||
AEROSPACE TECHNOLOGIES | 3Q 2025 | 3Q 2024 | Change | |||
Sales | | 15 % | ||||
Organic1 Growth | 12 % | |||||
Segment Profit | | 9 % | ||||
Segment Margin | 26.1 % | 27.7 % | -160 bps | |||
| ||||||
Sales | | (9 %) | ||||
Organic1 Growth | 1 % | |||||
Segment Profit | | (16 %) | ||||
Segment Margin | 18.8 % | 20.3 % | -150 bps | |||
BUILDING AUTOMATION | ||||||
Sales | | 8 % | ||||
Organic1 Growth | 7 % | |||||
Segment Profit | | 11 % | ||||
Segment Margin | 26.7 % | 25.9 % | 80 bps | |||
ENERGY AND SUSTAINABILITY SOLUTIONS | ||||||
Sales | | 11 % | ||||
Organic1 Growth | (2 %) | |||||
Segment Profit | | 11 % | ||||
Segment Margin | 24.5 % | 24.5 % | 0 bps | |||
1 | See additional information at the end of this release regarding non-GAAP financial measures. | |
2 | Segment margin and adjusted EPS are non-GAAP financial measures. Management cannot reliably predict or estimate, without unreasonable effort, the impact and timing on future operating results arising from items excluded from segment margin and adjusted EPS. We therefore, do not present a guidance range, or a reconciliation to, the nearest GAAP financial measures of operating margin or EPS. | |
3 | Adjusted EPS and adjusted EPS V% guidance excludes items identified in the non-GAAP reconciliation of adjusted EPS at the end of this release, and any potential future one-time items that we cannot reliably predict or estimate such as pension mark-to-market. | |
4 | 4Q24 financial results include impact of the Bombardier Agreement (BBD) announced on |
About
Additional Information
Forward Looking Statements
We describe many of the trends and other factors that drive our business and future results in this release. Such discussions contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including statements related to the planned spin-off of the Company's Advanced Materials business into Solstice Advanced Materials, a standalone, publicly traded company, the proposed separation of Automation and Aerospace Technologies, and the evaluation of strategic alternatives for the Productivity Solutions and Services and Warehouse and
This release contains financial measures presented on a non-GAAP basis.
- Segment profit, on an overall
Honeywell basis; - Segment profit margin, on an overall
Honeywell basis; - Organic sales growth;
- Free cash flow;
- Adjusted earnings per share; and
- Sales excluding personal protective equipment business.
Management believes that, when considered together with reported amounts, these measures are useful to investors and management in understanding our ongoing operations and in the analysis of ongoing operating trends. These measures should be considered in addition to, and not as replacements for, the most comparable GAAP measure. Certain measures presented on a non-GAAP basis represent the impact of adjusting items net of tax. The tax-effect for adjusting items is determined individually and on a case-by-case basis. Refer to the Appendix attached to this release for reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures.
Consolidated Statement of Operations (Unaudited) (Dollars in millions, except per share amounts)
| |||||||
Three Months Ended | Nine Months Ended | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Product sales | $ 7,086 | $ 6,590 | $ 20,850 | $ 19,330 | |||
Service sales | 3,322 | 3,138 | 9,732 | 9,080 | |||
Net sales | 10,408 | 9,728 | 30,582 | 28,410 | |||
Costs, expenses and other | |||||||
Cost of products sold | 4,734 | 4,166 | 13,533 | 12,448 | |||
Cost of services sold | 2,127 | 1,813 | 5,694 | 4,970 | |||
Total Cost of products and services sold | 6,861 | 5,979 | 19,227 | 17,418 | |||
Research and development expenses | 497 | 368 | 1,417 | 1,110 | |||
Selling, general and administrative expenses | 1,296 | 1,398 | 4,085 | 4,061 | |||
Impairment of assets held for sale | — | 125 | 15 | 125 | |||
Other (income) expense | (822) | (263) | (1,109) | (740) | |||
Interest and other financial charges | 354 | 297 | 970 | 767 | |||
Total costs, expenses and other | 8,186 | 7,904 | 24,605 | 22,741 | |||
Income before taxes | 2,222 | 1,824 | 5,977 | 5,669 | |||
Tax expense | 363 | 409 | 1,082 | 1,219 | |||
Net income | 1,859 | 1,415 | 4,895 | 4,450 | |||
Less: Net income attributable to noncontrolling interest | 34 | 2 | 51 | 30 | |||
Net income attributable to | $ 1,825 | $ 1,413 | $ 4,844 | $ 4,420 | |||
Earnings per share of common stock - basic | $ 2.87 | $ 2.17 | $ 7.57 | $ 6.79 | |||
Earnings per share of common stock - assuming dilution | $ 2.86 | $ 2.16 | $ 7.52 | $ 6.75 | |||
Weighted average number of shares outstanding - basic | 635.3 | 650.4 | 640.3 | 651.0 | |||
Weighted average number of shares outstanding - assuming dilution | 638.8 | 654.1 | 644.0 | 655.2 | |||
Segment Data (Unaudited) (Dollars in millions)
| |||||||
Three Months Ended | Nine Months Ended | ||||||
Net sales | 2025 | 2024 | 2025 | 2024 | |||
Aerospace Technologies | $ 4,511 | $ 3,912 | $ 12,990 | $ 11,472 | |||
2,274 | 2,501 | 7,032 | 7,485 | ||||
Building Automation | 1,878 | 1,745 | 5,396 | 4,742 | |||
Energy and Sustainability Solutions | 1,742 | 1,563 | 5,140 | 4,692 | |||
Corporate and All Other | 3 | 7 | 24 | 19 | |||
Total Net sales | $ 10,408 | $ 9,728 | $ 30,582 | $ 28,410 | |||
Reconciliation of Segment Profit to Income Before Taxes
| |||||||
Three Months Ended | Nine Months Ended | ||||||
Segment profit | 2025 | 2024 | 2025 | 2024 | |||
Aerospace Technologies | $ 1,178 | $ 1,082 | $ 3,375 | $ 3,177 | |||
428 | 508 | 1,308 | 1,459 | ||||
Building Automation | 502 | 452 | 1,421 | 1,199 | |||
Energy and Sustainability Solutions | 427 | 383 | 1,216 | 1,091 | |||
Corporate and All Other | (128) | (129) | (289) | (337) | |||
Total Segment profit | 2,407 | 2,296 | 7,031 | 6,589 | |||
Interest and other financial charges | (354) | (297) | (970) | (767) | |||
Interest income1 | 86 | 110 | 255 | 325 | |||
Amortization of acquisition-related intangibles2 | (141) | (120) | (410) | (275) | |||
Impairment of assets held for sale | — | (125) | (15) | (125) | |||
Stock compensation expense3 | (36) | (45) | (154) | (153) | |||
Pension ongoing income4 | 150 | 145 | 390 | 430 | |||
Pension mark-to-market expense4 | — | — | (14) | — | |||
Other postretirement income4 | 3 | 3 | 11 | 13 | |||
Repositioning and other gains (charges)5,6 | 367 | (52) | 283 | (189) | |||
Other expense7 | (260) | (91) | (430) | (179) | |||
Income before taxes | $ 2,222 | $ 1,824 | $ 5,977 | $ 5,669 | |||
1 | Amounts included in Other (income) expense. | |
2 | Amounts included in Cost of products and services sold. | |
3 | Amounts included in Selling, general and administrative expenses. | |
4 | Amounts included in Cost of products and services sold (service cost component), Selling, general and administrative expenses (service cost component), Research and development expenses (service cost component), and Other (income) expense (non-service cost component). | |
5 | Amounts included in Cost of products and services sold, Selling, general and administrative expenses, and Other (income) expense. | |
6 | Includes repositioning, asbestos, and environmental gains (expenses). | |
7 | Amounts include the other components of Other (income) expense not included within other categories in this reconciliation. Equity income of affiliated companies is included in segment profit. |
Consolidated Balance Sheet (Unaudited) (Dollars in millions)
| |||
| | ||
ASSETS | |||
Current assets | |||
Cash and cash equivalents | $ 12,930 | $ 10,567 | |
Short-term investments | 429 | 386 | |
Accounts receivable, less allowances of | 8,923 | 7,819 | |
Inventories | 7,118 | 6,442 | |
Assets held for sale | — | 1,365 | |
Other current assets | 1,347 | 1,329 | |
Total current assets | 30,747 | 27,908 | |
Investments and long-term receivables | 1,568 | 1,394 | |
Property, plant and equipment—net | 6,681 | 6,194 | |
23,720 | 21,825 | ||
Other intangible assets—net | 7,149 | 6,656 | |
Insurance recoveries for asbestos-related liabilities | 159 | 171 | |
Deferred income taxes | 239 | 238 | |
Other assets | 10,654 | 10,810 | |
Total assets | $ 80,917 | $ 75,196 | |
LIABILITIES | |||
Current liabilities | |||
Accounts payable | $ 7,314 | $ 6,880 | |
Commercial paper and other short-term borrowings | 6,873 | 4,273 | |
Current maturities of long-term debt | 72 | 1,347 | |
Accrued liabilities | 8,380 | 8,348 | |
Liabilities held for sale | — | 408 | |
Total current liabilities | 22,639 | 21,256 | |
Long-term debt | 30,092 | 25,479 | |
Deferred income taxes | 1,900 | 1,787 | |
Postretirement benefit obligations other than pensions | 105 | 112 | |
Asbestos-related liabilities | 1,369 | 1,325 | |
Other liabilities | 7,058 | 6,076 | |
Redeemable noncontrolling interest | 7 | 7 | |
Shareowners' equity | 17,747 | 19,154 | |
Total liabilities, redeemable noncontrolling interest and shareowners' equity | $ 80,917 | $ 75,196 | |
Consolidated Statement of Cash Flows (Unaudited) (Dollars in millions)
| |||||||
Three Months Ended | Nine Months Ended | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Cash flows from operating activities | |||||||
Net income | $ 1,859 | $ 1,415 | $ 4,895 | $ 4,450 | |||
Less: Net income attributable to noncontrolling interest | 34 | 2 | 51 | 30 | |||
Net income attributable to | 1,825 | 1,413 | 4,844 | 4,420 | |||
Adjustments to reconcile net income attributable to | |||||||
Depreciation | 191 | 171 | 563 | 500 | |||
Amortization | 206 | 186 | 612 | 457 | |||
Loss on sale of non-strategic businesses and assets | — | — | 14 | — | |||
Impairment of assets held for sale | — | 125 | 15 | 125 | |||
Repositioning and other (gains) charges | (367) | 52 | (283) | 189 | |||
Net payments for repositioning and other charges | (84) | (118) | (279) | (329) | |||
Resideo indemnification and reimbursement agreement termination payment | 1,590 | — | 1,590 | — | |||
Pension and other postretirement income | (153) | (148) | (387) | (443) | |||
Pension and other postretirement benefit payments | (4) | (10) | (16) | (25) | |||
Stock compensation expense | 36 | 45 | 154 | 153 | |||
Deferred income taxes | 85 | (10) | 54 | (46) | |||
Other | (31) | (35) | (340) | (221) | |||
Changes in assets and liabilities, net of the effects of acquisitions and divestitures | |||||||
Accounts receivable | (117) | (69) | (1,035) | (218) | |||
Inventories | (100) | (156) | (604) | (233) | |||
Other current assets | (49) | (78) | (199) | (128) | |||
Accounts payable | 206 | 281 | 410 | (142) | |||
Accrued liabilities | 164 | 358 | 594 | 20 | |||
Income taxes | (110) | (10) | (503) | (263) | |||
Net cash provided by operating activities | 3,288 | 1,997 | 5,204 | 3,816 | |||
Cash flows from investing activities | |||||||
Capital expenditures | (374) | (279) | (928) | (771) | |||
Proceeds from disposals of property, plant and equipment | — | — | 23 | — | |||
Increase in investments | (384) | (230) | (1,065) | (698) | |||
Decrease in investments | 295 | 172 | 1,048 | 564 | |||
(Payments) receipts from settlements of derivative contracts | 12 | (326) | (403) | (250) | |||
Cash paid for acquisitions, net of cash acquired | (37) | (2,134) | (2,200) | (7,047) | |||
Proceeds from sale of business, net of cash transferred | — | — | 1,157 | — | |||
Net cash used for investing activities | (488) | (2,797) | (2,368) | (8,202) | |||
Cash flows from financing activities | |||||||
Proceeds from issuance of commercial paper and other short-term borrowings | 7,308 | 2,523 | 19,171 | 9,516 | |||
Payments of commercial paper and other short-term borrowings | (6,721) | (3,988) | (16,711) | (8,477) | |||
Proceeds from issuance of common stock | 42 | 40 | 140 | 349 | |||
Proceeds from issuance of long-term debt | — | 4,697 | 4,035 | 10,407 | |||
Payments of long-term debt | (246) | (776) | (1,555) | (1,381) | |||
Repurchases of common stock | (100) | — | (3,704) | (1,200) | |||
Cash dividends paid | (735) | (715) | (2,214) | (2,161) | |||
Other | 233 | (21) | 198 | 5 | |||
Net cash (used for) provided by financing activities | (219) | 1,760 | (640) | 7,058 | |||
Effect of foreign exchange rate changes on cash and cash equivalents | — | 108 | 167 | 47 | |||
Net increase in cash and cash equivalents | 2,581 | 1,068 | 2,363 | 2,719 | |||
Cash and cash equivalents at beginning of period | 10,349 | 9,576 | 10,567 | 7,925 | |||
Cash and cash equivalents at end of period | $ 12,930 | $ 10,644 | $ 12,930 | $ 10,644 | |||
Appendix
Non-GAAP Financial Measures
The following information provides definitions and reconciliations of certain non-GAAP financial measures presented in this press release to which this reconciliation is attached to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP).
Management believes that, when considered together with reported amounts, these measures are useful to investors and management in understanding our ongoing operations and in the analysis of ongoing operating trends. These measures should be considered in addition to, and not as replacements for, the most comparable GAAP measure. Certain measures presented on a non-GAAP basis represent the impact of adjusting items net of tax. The tax-effect for adjusting items is determined individually and on a case-by-case basis. Other companies may calculate these non-GAAP measures differently, limiting the usefulness of these measures for comparative purposes.
Management does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitations of these non-GAAP financial measures are that they exclude significant expenses and income that are required by GAAP to be recognized in the consolidated financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. Investors are urged to review the reconciliation of the non-GAAP financial measures to the comparable GAAP financial measures and not to rely on any single financial measure to evaluate
Reconciliation of Organic Sales Percent Change (Unaudited)
| |
Three Months Ended | |
| |
Reported sales percent change | 7 % |
Less: Foreign currency translation | 1 % |
Less: Acquisitions, divestitures and other, net | — % |
Organic sales percent change | 6 % |
Aerospace Technologies | |
Reported sales percent change | 15 % |
Less: Foreign currency translation | — % |
Less: Acquisitions, divestitures and other, net | 3 % |
Organic sales percent change | 12 % |
| |
Reported sales percent change | (9) % |
Less: Foreign currency translation | 1 % |
Less: Acquisitions, divestitures and other, net | (11) % |
Organic sales percent change | 1 % |
Building Automation | |
Reported sales percent change | 8 % |
Less: Foreign currency translation | 1 % |
Less: Acquisitions, divestitures and other, net | — % |
Organic sales percent change | 7 % |
Energy and Sustainability Solutions | |
Reported sales percent change | 11 % |
Less: Foreign currency translation | 1 % |
Less: Acquisitions, divestitures and other, net | 12 % |
Organic sales percent change | (2) % |
We define organic sales percentage as the year-over-year change in reported sales relative to the comparable period, excluding the impact on sales from foreign currency translation and acquisitions, net of divestitures, for the first 12 months following the transaction date. We believe this measure is useful to investors and management in understanding our ongoing operations and in analysis of ongoing operating trends.
A quantitative reconciliation of reported sales percent change to organic sales percent change has not been provided for the forward-looking measure of organic sales percent change because management cannot reliably predict or estimate, without unreasonable effort, the fluctuations in global currency markets that impact foreign currency translation, nor is it reasonable for management to predict the timing, occurrence and impact of acquisition and divestiture transactions, all of which could significantly impact our reported sales percent change.
Reconciliation of Reported Sales to Sales Excluding Personal Protective Equipment Business (Unaudited) (Dollars in millions)
| |||
Three Months Ended | Three Months Ended | ||
2025 | 2025 | ||
| |||
Reported sales | $ 2,274 | $ 2,380 | |
Sales attributable to the personal protective equipment business | — | 145 | |
Sales excluding personal protective equipment business | $ 2,274 | $ 2,235 | |
Sequential growth percent change | 2 % | ||
We define sales excluding personal protective equipment business as reported sales less sales attributable to the personal protective equipment business. We believe this measure is useful to investors and management in understanding our ongoing operations and in analysis of ongoing operating trends.
Reconciliation of Operating Income to Segment Profit, Calculation of Operating Income and Segment Profit Margins (Unaudited) (Dollars in millions)
| |||||
Three Months Ended | Twelve Months Ended | ||||
2025 | 2024 | 2024 | |||
Operating income | $ 1,754 | $ 1,858 | $ 7,441 | ||
Stock compensation expense1 | 36 | 45 | 194 | ||
Repositioning, Other2,3 | 448 | 69 | 292 | ||
Pension and other postretirement service costs4 | 19 | 16 | 65 | ||
Amortization of acquisition-related intangibles5 | 141 | 120 | 415 | ||
Acquisition-related costs6 | 9 | 15 | 25 | ||
Indefinite-lived intangible asset impairment1 | — | 48 | 48 | ||
Impairment of assets held for sale | — | 125 | 219 | ||
Segment profit | $ 2,407 | $ 2,296 | $ 8,699 | ||
Operating income | $ 1,754 | $ 1,858 | $ 7,441 | ||
÷ Net sales | $ 10,408 | $ 9,728 | $ 38,498 | ||
Operating income margin % | 16.9 % | 19.1 % | 19.3 % | ||
Segment profit | $ 2,407 | $ 2,296 | $ 8,699 | ||
÷ Net sales | $ 10,408 | $ 9,728 | $ 38,498 | ||
Segment profit margin % | 23.1 % | 23.6 % | 22.6 % | ||
1 | Included in Selling, general and administrative expenses. | |
2 | Includes repositioning, asbestos, environmental expenses, equity income adjustment, and other charges. | |
3 | Included in Cost of products and services sold and Selling, general and administrative expenses. | |
4 | Included in Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |
5 | Included in Cost of products and services sold. | |
6 | Included in Other (income) expense. Includes acquisition-related fair value adjustments to inventory and third-party transaction and integration costs. |
We define operating income as net sales less total cost of products and services sold, research and development expenses, impairment of assets held for sale, and selling, general and administrative expenses. We define segment profit, on an overall
A quantitative reconciliation of operating income to segment profit, on an overall
Acquisition amortization and acquisition- and divestiture-related costs are significantly impacted by the timing, size, and number of acquisitions or divestitures we complete and are not on a predictable cycle and we make no comment as to when or whether any future acquisitions or divestitures may occur. We believe excluding these costs provides investors with a more meaningful comparison of operating performance over time and with both acquisitive and other peer companies.
Reconciliation of Earnings per Share to Adjusted Earnings per Share (Unaudited)
| |||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||
2025 | 2024 | 2024 | 2025(E) | ||||||||
Guidance | Less: | Guidance | |||||||||
Earnings per share of common stock - diluted1 | $ 2.86 | $ 2.16 | $ 8.71 | | $ 0.21 | | |||||
Pension mark-to-market expense2 | — | — | 0.14 | No Forecast | — | No Forecast | |||||
Amortization of acquisition-related intangibles3 | 0.17 | 0.14 | 0.49 | 0.72 | — | 0.72 | |||||
Acquisition-related costs4 | 0.03 | 0.03 | 0.09 | 0.05 | — | 0.05 | |||||
Divestiture-related costs5 | 0.60 | — | 0.04 | No Forecast | — | No Forecast | |||||
Russian-related charges6 | — | — | 0.03 | — | — | — | |||||
Indefinite-lived intangible asset impairment7 | — | 0.06 | 0.06 | — | — | — | |||||
Impairment of assets held for sale8 | — | 0.19 | 0.33 | 0.02 | — | 0.02 | |||||
Loss on sale of business9 | — | — | — | 0.04 | — | 0.04 | |||||
Gain related to Resideo indemnification and reimbursement agreement termination10 | (1.26) | — | — | (1.25) | — | (1.25) | |||||
Adjustment to estimated future environmental liabilities11 | 0.25 | — | — | 0.25 | — | 0.25 | |||||
Loss on expected settlement of divestiture of asbestos liabilities12 | 0.17 | — | — | 0.17 | — | 0.17 | |||||
Adjusted earnings per share of common stock - diluted | $ 2.82 | $ 2.58 | $ 9.89 | $10.81 - $10.91 | $ 0.21 | $10.60 - $10.70 | |||||
1 | For the three months ended September 30, 2025, and 2024, adjusted earnings per share utilizes weighted average shares of approximately 638.8 million and 654.1 million, respectively. For the twelve months ended December 31, 2024, adjusted earnings per share utilizes weighted average shares of approximately 655.3 million. For the twelve months ended December 31, 2025, expected earnings per share utilizes weighted average shares of approximately 643 million. | |
2 | For the twelve months ended December 31, 2024, pension mark-to-market expense was $95 million, net of tax benefit of $31 million. | |
3 | For the three months ended September 30, 2025, and 2024, acquisition-related intangibles amortization includes $107 million and $95 million, net of tax benefit of $34 million and $25 million, respectively. For the twelve months ended December 31, 2024, acquisition-related intangibles amortization includes $324 million, net of tax benefit of $91 million. For the twelve months ended December 31, 2025, expected acquisition-related intangibles amortization includes approximately $460 million, net of tax benefit of approximately $110 million. | |
4 | For the three months ended September 30, 2025, and 2024, the adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, was $17 million and $20 million, net of tax benefit of $5 million and $5 million, respectively. For the twelve months ended December 31, 2024, the adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, was $59 million, net of tax benefit of $16 million. For the twelve months ended December 31, 2025, the expected adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, is approximately $35 million, net of tax benefit of approximately $10 million. | |
5 | For the three months ended September 30, 2025, the adjustment for divestiture-related costs, which is principally comprised of third-party transaction and separation costs, was $382 million, net of tax expense of $115 million. For the twelve months ended December 31, 2024, the adjustment for divestiture-related costs, which is principally comprised of third-party transaction costs, was $23 million, net of tax benefit of $6 million. | |
6 | For the twelve months ended December 31, 2024, the adjustment for Russian-related charges was a $17 million expense, without tax benefit, due to the settlement of a contractual dispute with a Russian entity associated with the Company's suspension and wind down activities in | |
7 | For the three months ended September 30, 2024, and twelve months ended December 31, 2024, the impairment charge of indefinite-lived intangible assets associated with the personal protective equipment business was $37 million, net of tax benefit of $11 million. | |
8 | For the three months ended September 30, 2024, and twelve months ended December 31, 2024, the impairment charge of assets held for sale was $125 million and $219 million, respectively, without tax benefit. For the twelve months ended December 31, 2025, the expected impairment charge of assets held for sale is $15 million, without tax benefit. | |
9 | For the twelve months ended December 31, 2025, the expected adjustment for loss on sale of the personal protective equipment business is $28 million, net of tax benefit of $2 million. | |
10 | For the three months ended September 30, 2025, the adjustment for the gain related to the Resideo indemnification and reimbursement agreement termination was $802 million, without tax expense. For the twelve months ended December 31, 2025, the expected gain related to the Resideo indemnification and reimbursement agreement termination is $802 million, without tax expense. | |
11 | In the three months ended September 30, 2025, the Company enhanced its process for estimating environmental liabilities at sites undergoing active remediation, which led to earlier recognition of the estimated probable liabilities and an increase to estimated environmental liabilities. For the three months ended September 30, 2025, the adjustment to increase environmental liabilities was $161 million, net of tax benefit of $50 million. For the twelve months ended December 31, 2025, the expected adjustment is $161 million, net of tax benefit of $50 million. | |
12 | For the three months ended September 30, 2025, the adjustment for loss on expected settlement of divestiture of asbestos liabilities was $112 million, net of tax benefit of $36 million. For the twelve months ended December 31, 2025, the expected adjustment is $112 million, net of tax benefit of $36 million. | |
13 | The forecasted earnings for Advanced Materials for November and December 2025 are excluded due to the expected October 30, 2025 spin-off. |
Reconciliation of Earnings per Share to Adjusted Earnings per Share (Continued)
(Unaudited)
We define adjusted earnings per share as diluted earnings per share adjusted to exclude various charges as listed above. We believe adjusted earnings per share is a measure that is useful to investors and management in understanding our ongoing operations and in analysis of ongoing operating trends. For forward-looking information, management cannot reliably predict or estimate, without unreasonable effort, the pension mark-to-market expense or the divestiture-related costs. The pension mark-to-market expense is dependent on macroeconomic factors, such as interest rates and the return generated on invested pension plan assets. The divestiture-related costs are subject to detailed development and execution of separation restructuring plans for the announced separation of Automation and Aerospace Technologies. We therefore do not include an estimate for the pension mark-to-market expense or divestiture-related costs. Based on economic and industry conditions, future developments, and other relevant factors, these assumptions are subject to change.
Acquisition amortization and acquisition- and divestiture-related costs are significantly impacted by the timing, size, and number of acquisitions or divestitures we complete and are not on a predictable cycle and we make no comment as to when or whether any future acquisitions or divestitures may occur. We believe excluding these costs provides investors with a more meaningful comparison of operating performance over time and with both acquisitive and other peer companies.
Reconciliation of Cash Provided by Operating Activities to Free Cash Flow (Unaudited) (Dollars in millions)
| |||||
Three Months Ended September 30, 2025 | Three Months Ended September 30, 2024 | Twelve Months Ended December 31, 2024 | |||
Cash provided by operating activities | $ 3,288 | $ 1,997 | $ 6,097 | ||
Capital expenditures | (374) | (279) | (1,164) | ||
Spin-off and separation-related cost payments | 126 | — | — | ||
Resideo indemnification and reimbursement agreement termination payment | (1,590) | — | — | ||
Free cash flow | $ 1,450 | $ 1,718 | $ 4,933 | ||
We define free cash flow as cash provided by operating activities less cash for capital expenditures and excluding spin-off and separation-related cost payments, the Resideo indemnification and reimbursement agreement termination payment, and the cash payment for settlement of divestiture of asbestos liabilities.
We believe that free cash flow is a non-GAAP measure that is useful to investors and management as a measure of cash generated by operations that will be used to repay scheduled debt maturities and can be used to invest in future growth through new business development activities or acquisitions, pay dividends, repurchase stock, or repay debt obligations prior to their maturities. This measure can also be used to evaluate our ability to generate cash flow from operations and the impact that this cash flow has on our liquidity.
Reconciliation of Expected Cash Provided by Operating Activities to Expected Free Cash Flow (Unaudited) (Dollars in billions)
| |||||
Twelve Months Ended December 31, 2025(E) | |||||
Guidance | Less: Solstice | Guidance | |||
Cash provided by operating activities | ~$6.6 - $7.0 | ~$0.2 | ~$6.4 - $6.8 | ||
Capital expenditures | ~(1.3) | — | ~(1.3) | ||
Spin-off and separation-related cost payments | ~0.3 | — | ~0.3 | ||
Resideo indemnification and reimbursement agreement termination payment | ~(1.6) | — | ~(1.6) | ||
Impact of expected settlement of divestiture of asbestos liabilities | ~1.4 | — | ~1.4 | ||
Free cash flow | ~$5.4 - $5.8 | ~$0.2 | ~$5.2 - $5.6 | ||
1 | The forecasted operating cash flow and free cash flow for Advanced Materials' for November and December 2025 are excluded due to spin-off expected October 30, 2025. |
We define free cash flow as cash provided by operating activities less cash for capital expenditures and excluding spin-off and separation-related cost payments, the Resideo indemnification and reimbursement agreement termination payment, and the cash payment for settlement of divestiture of asbestos liabilities.
We believe that free cash flow is a non-GAAP measure that is useful to investors and management as a measure of cash generated by operations that will be used to repay scheduled debt maturities and can be used to invest in future growth through new business development activities or acquisitions, pay dividends, repurchase stock, or repay debt obligations prior to their maturities. This measure can also be used to evaluate our ability to generate cash flow from operations and the impact that this cash flow has on our liquidity.
Contacts: | |
Media | Investor Relations |
(980) 378-6258 | (704) 627-6200 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/
SOURCE
